The IgM in three patients with paraproteinemia and peripheral neuropathy was shown to bind to human myelin-associated glycoprotein (MAG) that had been purified to homogeneity by gel filtration on Sepharose CL-6B. The antigenic determinant reacting with the IgM from all three patients was in the carbohydrate part of the MAG molecule. In addition, the IgM from the same three patients bound to a single ganglioside of human sciatic nerve. The results indicate that the IgM paraproteins in these patients react with a carbohydrate determinant that is shared between MAG and a peripheral nerve ganglioside.
Some patients producing large amounts of monoclonal IgM due to plasma cell dyscrasia have a demyelinating peripheral neuropathy (1) . There is evidence to suggest that the neuropathies are caused by binding of the IgM paraproteins to peripheral nerve antigens (2) (3) (4) (5) (6) (7) (8) (9) , although this has not been established. Experiments in several laboratories have provided evidence that the monoclonal IgM in some of these patients binds to the myelin-associated glycoprotein (MAG) (10) (11) (12) (13) (14) . In this paper, it is demonstrated that the monoclonal IgM antibodies in three neuropathy patients of this type bind to human MAG purified to homogeneity by the procedure routinely used in our laboratory for chemical studies on this glycoprotein (15) . It is further shown that the antibodies are directed against determinants in the carbohydrate part of the MAG molecule. Experiments are also described, however, which indicate that the IgM antibodies produced by the same patients bind to a ganglioside of human sciatic nerve. The results indicate that there are at least two molecules in peripheral nerve containing the carbohydrate antigen that reacts with the paraproteins produced by these patients. If the monoclonal IgM causes the neuropathy in these patients, both MAG and the ganglioside are candidates to be involved in the dysimmune phenomena. Some of the results reported here have been described in abstract form (13, 16) .
MATERIALS AND METHODS
Patients. After informed consent was obtained, four patients with IgM paraproteinemia and peripheral neuropathy were studied at the National Institute of Neurological and Communicative Disorders and Stroke. The patients were studied clinically, electromyographically, and by examination of sural nerve biopsies as described (6) . Fractionation and identification of serum monoclonal proteins was performed by high-resolution agarose gel electrophoresis combined with immunofixation using specific antisera against human immunoglobulin heavy chains and K and X light chains.
Preparative and Analytical Procedures with MAG. Human and rat MAG were selectively extracted from the purified myelin by the lithium diiodosalicylate/phenol procedure (17) and further purified by gel filtration on Sepharose CL-6B as described (15) . Deglycosylation of partially purified MAG obtained by the lithium diiodosalicylate/phenol procedure was carried out with trifluoromethanesulfonic acid (18) . The polyclonal rabbit antisera to MAG were prepared and characterized as described (19) . The IgG monoclonal antibody (7E10) was prepared from mice immunized with rat MAG (20) , and the mouse IgM monoclonal antibody to human MAG was prepared by a similar procedure. Electrophoresis was on NaDodSO4 10% (wt/vol) polyacrylamide gels (21) that were stained for protein with Coomassie blue or for carbohydrate with periodic acid/Schiff reagents (22) . For immunostaining, proteins were transferred to nitrocellulose sheets essentially by the procedure of Towbin et al. (23) . Immune staining was with appropriate peroxidase-labeled second antibodies and 3,3'-diaminobenzidine as substrate. Immune staining with the patients' sera was achieved with peroxidase-labeled goat anti-human IgM, ,A-chain specific, obtained from Cappel Laboratories (Cochcranville, PA). Concanavalip A binding to MAG that had been transferred to nitrocellulose strips was demonstrated with horseradish peroxidase according to the principle utilized by Wood and McLaughlin (24) with blocking and washing procedures similar to those of Glass et al. (25) . Column-purified MAG was radioiodinated with Bolton-Hunter reagent and immune precipitated with rabbit anti-MAG antiserum followed by goat anti-rabbit IgG as described (26) . Double-antibody precipitation of 1251-labeled MAG with the sera from human patients or controls was done by an exactly analogous procedure, except that the incubation included 25 ,tg of human IgM (Cappel) as carrier and the second antibody was rabbit anti-human IgM (,u-chain specific) made by Dako and obtained from Accurate Chemicals (Westbury, NY).
Preparative and Analytical Procedures with Gangliosides. Ganglioside fractions were isolated from human sciatic nerve and brain by DEAE-Sephadex chromatography, alkali treatment, and Unisil chromatography as described by Ledeen et al. (27) . GM1 and GDia standards were purchased from Supelco (Bellefonte, PA). The amount of gangliosidesialic acid was measured by the thiobarbituric acid procedure (28) .
Binding of human IgM to the ganglioside fraction was determined by an ELISA procedure in the following manner. Gangliosides in 20 ,ul of methanol were added to wells in Linbro enzyme immunoassay microtitration plates (Flow Laboratories) and the solution was dried by evaporation. The wells were then filled with phosphate-buffered saline at Abbreviation: MAG, myelin-associated glycoprotein. *To whom reprint requests should be addressed.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (Fig. 1B) Reactivity with the purified human MAG was also demonstrated by a double-antibody precipitation using the purified human MAG that had been radioiodinated with BoltonHunter reagent as the antigen (Table 1) . The maximal radioactivity that could be precipitated by the patients' sera was comparable to that precipitated by known rabbit anti-MAG antiserum. This shows that the component reacting with the 15 ,ug; C, 220 ng; D-G, 500 ng. The MAG and deglycosylated MAG on the various lanes ran as two closely spaced bands representing MAG and a slightly lower molecular weight derivative (dMAG) formed by a protease in purified myelin that has been described (31) . The lower molecular weight derivative was more evident in the deglycosylated sample in most cases, probably because it was recovered in somewhat better yield than intact MAG from the deglycosylation step.
had been immunized with isolated rat MAG (20) . Although the 1gM in a patient with paraproteinemia and peripheral neuropathy stained the intact MAG well, it showed no reactivity with the deglycosylated MAG. The same result was obtained with serum from each of the three patients that showed reactivity with intact MAG (patients A-C). The mouse IgM monoclonal antibody described in Fig. 1C also resembled those produced by the patients in reacting with intact MAG but not with the deglycosylated form of the molecule.
Binding of the IgM to a Ganglioside. IgM from the three patients that reacted with MAG also reacted strongly with human sciatic nerve gangliosides in an ELISA ( Table 2) . Binding of IgM in normal serum or that from patient D was much less. (The elevated absorbance given by serum from patient D in comparison to normal serum is not due to simply nonspecific binding as a result of the high IgM level. Unpublished TLC overlay experiments indicate that this patient's IgM binds to a different ganglioside from the one reacting with the IgM of patients A-C.) The IgM from patients A-C did not react with a ganglioside fraction prepared in the same manner from human brain. The mouse IgM monoclonal antibody raised to human MAG again resembled the patients' IgM in giving a positive reaction to the human sciatic nerve ganglioside fraction (data not shown).
Further evidence for the existence of a ganglioside antigen reacting with the IgM from these three patients with paraproteinemia was obtained by overlaying thin-layer chromatograms of the sciatic nerve ganglioside fraction with the patients' sera followed by radioiodinated goat anti-human IgM. Fig. 3 shows that patient A's IgM bound to a single component on the TLC plate corresponding to one of the fainter gangliosides revealed by resorcinol stain. The IgM from patients B and C bound to the same ganglioside. Overlay experiments also showed that the mouse IgM monoclonal antibody prepared experimentally to human MAG reacted with the same ganglioside, again emphasizing its similarity to the IgM in the neuropathy patients. The results suggest that the human and mouse IgM monoclonal antibodies are reacting with the ganglioside revealed by resorcinol stain (Fig. 3A) , but the possibility that the antigen is a very minor ganglioside co-chromatographing with the more prominent compo- nent has not yet been ruled out. Comparison with known standards showed that the ganglioside reacting with the IgM chromatographed slower than GM1 and slightly faster than GDla. DISCUSSION Reactivity of the monoclonal IgM in several patients with paraproteinemia and peripheral neuropathy was demonstrated with MAG purified by a procedure developed in our laboratory for obtaining this glycoprotein in homogeneous form for chemical studies (15) . IgM binding to the purified MAG was shown both by immunoblotting experiments and by double-antibody precipitation of 125I-labeled MAG. Use of the purified protein confirms and strengthens the evidence now accumulating from several laboratories that MAG is a common antigen reacting with the monoclonal IgM in many patients with paraproteinemia and peripheral neuropathy (10) (11) (12) (13) (14) . Although all of the results described in this paper were obtained with sera from three patients seen in the National Institutes of Health clinical center, screening of sera sent to us from other laboratories has resulted in the identification of more than 15 patients with paraproteinemia associated with peripheral neuropathy in which the IgM reacts with MAG, including some patients cited in other reports (8, 11 The finding that the IgM from these patients reacts with a ganglioside of peripheral nerve in addition to MAG indicates that there are at least two antigens in the nerve that may be involved in the pathology. It has not been established that the IgM paraproteins in these patients cause the neuropathy by binding to a peripheral nerve antigen, but if they do, either MAG or the ganglioside, or both, could be the significant target antigen. On the other hand, the paraproteinemia in the patients may result from the proliferation of a B-cell clone subsequent to the onset of the neuropathy (9) . An autoimmune reaction to the carbohydrate antigen may develop as a secondary response to a preexisting neuropathy, and the chance that the proliferating B cell is one producing anti-MAG (or ganglioside) antibodies would thereby be increased. In either case, the findings indicate that the carbohydrate antigen shared by MAG and the ganglioside is highly immunogenic. Production of antibodies to gangliosides in response to peripheral nerve injury in mice has been described (32) . Even if the IgM antibodies do not cause the neuropathy in the patients with paraproteinemia, interaction of the monoclonal antibodies with the carbohydrate antigens may be clinically significant by preventing remyelination.
Other examples of carbohydrate antigens shared by glycoproteins and glycolipids have been described (33) (34) (35) . The sciatic nerve ganglioside reacting with the IgM in these patients with paraproteinemia was not detected in the ganglioside fraction from brain. Because it chromatographs slower than GM1 but faster than GD1a, it is probably a mono-or disialo-ganglioside. It is apparently not LM1, a glucosaminecontaining ganglioside of the lacto series, which has been shown to be a major component of peripheral nerve gangliosides (36) (37) (38) (40, 41) .
The quantitative preponderance of the ganglioside antigen suggests that it may be more significant in the pathology of the disease, although the presence of MAG in critical structures of myelin sheaths (41) indicates that it could also be of prime importance. Indeed, MAG has been shown to be altered early in the pathological changes of central nervous system myelin sheaths in multiple sclerosis (42, 43) . Both MAG and the ganglioside must be considered as potentially causal antigens in the pathogenesis of neuropathy of this type.
